- Supported exchanges /
- KQ /
- 246960.KQ
InnoTherapy Inc (246960 KQ) stock market data APIs
SCL Science Inc., engages in the development and sale of medical sealant products in South Korea. The company's products include InnoSEAL, an externally applied hemostatic agent; InnoSEAL Plus, an absorbable hemostatic pad; EndoSil, an absorbable hemostatic agent used for the gastrointestinal oozing bleeding; GellySil, a biomaterial and the proprietary material product. It also provides Film-type surgical sealant to complete sealing of anastomosis site; STOP needle, a self-sealing needle for general and ophthalmic use; wound dressing used for chronic wounds, burns, etc.; and Gene therapy, a bio-therapeutics delivery system. The company was formerly known as InnoTherapy, Inc. and changed its name to SCL Science Inc. in March 2024. SCL Science Inc. was founded in 2010 and is headquartered in Seoul, South Korea.
InnoTherapy Inc Financial Data Overview
| 8480 | |
| 8380 | |
| - | |
| 8600 | |
| 8370 | |
| 7600-11850 | |
| 62 419 M | |
| 7 283 K | |
| 3 059 M | |
| -112.9009 | |
| 0.777 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
InnoTherapy Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 3 059 M
- EBITDA -2 386 413 568
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get InnoTherapy Inc Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get InnoTherapy Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
